Assessing Predictors of Acute and Chronic Thrombotic Microangiopathy in Native and Allograft Biopsies
American Journal of Nephrology · 2025
DOI: 10.1159/000542025 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift American Journal of Nephrology, 2025. Verfasst von Anam Tariq und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Renal and Hypertension, George Washington University, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: Thrombotic Microangiopathies, Kidney Transplantation, Kidney. Die Arbeit nennt 29 Literaturangaben. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Introduction
Thrombotic microangiopathies (TMAs) represent distinct pathological and clinical entities with known chronicity and recurrence. Kidney biopsy is the gold standard to diagnose TMA in patients with renal manifestations, but the prognostic significance of acute or chronic phase of the disease has not been well studied. We examined the clinical characteristics, management, and predictors of acute versus chronic TMA among native and transplants.
Methods
Observational, cross-sectional study of a 22-year period at Johns Hopkins Hospital. Prevalence of acute versus chronic TMA was based on specific histology identified on native and allograft kidney biopsies. Predictors of acute and chronic TMA were assessed using simple linear regression and odds ratios.
Results
Among 127 patients, 29 (23%) had chronic TMA and 98 (77%) had acute TMA, with 60% female and 43 ± 18 years of age. Chronic TMA was significantly associated with a history of lupus or hemolytic uremic syndrome (HUS) and the use of clopidogrel or mammalian target of rapamycin inhibitors (mTORi). Specifically, chronic TMA was significantly associated with use of mTORi in native kidneys. The odds of chronic TMA compared to acute TMA were lower for each race (Caucasians, 76%; blacks, 38%; Hispanics and Asians, 22%).
Conclusions
A kidney biopsy may not necessarily be needed to determine the presence of chronic TMA since certain predictors, as those demonstrated by our study (use of mTORi and history of lupus or HUS), independently predicted higher odds of developing chronic TMA and its sequelae conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Renal and Hypertension, George Washington University, Washington, District of Columbia, USA.
- Division of Nephrology, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Tariq, A., Raj, D., Tariq, A., Arend, L., & Atta, M. G. (2025). Assessing Predictors of Acute and Chronic Thrombotic Microangiopathy in Native and Allograft Biopsies. American Journal of Nephrology. https://doi.org/10.1159/000542025
Vancouver
Tariq A, Raj D, Tariq A, Arend L, Atta MG. Assessing Predictors of Acute and Chronic Thrombotic Microangiopathy in Native and Allograft Biopsies. American Journal of Nephrology. 2025. doi:10.1159/000542025
BibTeX
@article{Tariq2025,
author = {Tariq, Anam and Raj, Dominic and Tariq, Azka and Arend, Lois and Atta, Mohamed G},
title = {Assessing Predictors of Acute and Chronic Thrombotic Microangiopathy in Native and Allograft Biopsies},
journal = {American Journal of Nephrology},
year = {2025},
doi = {10.1159/000542025}
}
EUVIMED